Involvement of the TNF-α/SATB2 axis in the induced apoptosis and inhibited autophagy of osteoblasts by the antipsychotic Risperidone
Open Access
- 3 May 2022
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-18
Abstract
Background: Risperidone, an atypical antipsychotic, impedes serotonin and dopamine receptor systems. Meanwhile, tumor necrosis factor-α (TNF-α) is known to participate in regulating osteoblast functions. Consequently, the current study aimed to investigate whether the influences of Risperidone on osteoblast functions are associated with TNF-α and special AT-rich sequence-binding protein (SATB2).Methods: Firstly, we searched the DGIdb, MEM and GeneCards databases to identify the critical factors involved in the effects of Risperidone on osteoblasts, as well as their interactions. Afterwards, osteoblast cell line MC3T3-E1 was transduced with lentivirus carrying si-TNF-α, si-SATB2 or both and subsequently treated with Risperidone. Various abilities including differentiation, autophagy and apoptosis of osteoblasts were examined after different treatments. Finally, animal experiments were performed with Risperidone alone or together with lentivirus to verify the function of Risperidone in vivo and the mechanism.Results: It was found that Risperidone might promote TNF-α expression, thereby inhibiting the expression of SATB2 to affect the autophagy and apoptosis in osteoblasts. Furthermore, as shown by our experimental findings, Risperidone treatment inhibited the differentiation and autophagy, and promoted the apoptosis of osteoblasts, as evidenced by elevated levels of OPG, p62, cleaved PARP1, cleaved caspase-3, cleaved caspase-8, and cleaved caspase-9, and reduced levels of LC3 II/I, Beclin1, collagen I, and RANKL. In addition, Risperidone was also found to elevate the expression of TNF-α to down-regulate SATB2, thereby inhibiting the differentiation and autophagy and enhancing the apoptosis of osteoblasts in vitro and in vivo.Conclusions: Collectively, our findings indicated that Risperidone affects the differentiation of osteoblasts by inhibiting autophagy and enhancing apoptosis via TNF-α-mediated down-regulation of SATB2.Keywords
Funding Information
- Guangdong science and technology special fund in 2020 (Shan Fu Ke letter (2020) 53, Project ID: 200113165875501, 200115105879476)
- Special fund for science and technology innovation strategy of Guangdong Province in 2018 (Shan Fu Ke letter (2018) 157)
This publication has 39 references indexed in Scilit:
- Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gainBone, 2012
- Robust rank aggregation for gene list integration and meta-analysisBioinformatics, 2012
- SATB2 participates in regulation of menadione‐induced apoptotic insults to osteoblastsJournal of Orthopaedic Research, 2012
- Special AT-rich sequence-binding protein 2 and its related genes play key roles in the differentiation of MC3T3-E1 osteoblast like cellsBiochemical and Biophysical Research Communications, 2012
- Roles of SATB2 in Osteogenic Differentiation and Bone RegenerationTissue Engineering Part A, 2011
- The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralizationJournal of Tissue Engineering and Regenerative Medicine, 2011
- Effect of IL‐1β, PGE2, and TGF‐β1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblastsJournal of Cellular Biochemistry, 2010
- TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signalingBiochemical and Biophysical Research Communications, 2007
- Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cellsJournal of Endocrinology, 2007
- RANKL Expression Is Related to the Differentiation State of Human OsteoblastsJournal of Bone and Mineral Research, 2003